Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;65(4):754-762.
doi: 10.1111/jgs.14671. Epub 2016 Nov 15.

Beta-Blocker Use in U.S. Nursing Home Residents After Myocardial Infarction: A National Study

Andrew R Zullo  1 , Yoojin Lee  1 , Lori A Daiello  1 , Vincent Mor  1   2 , W John Boscardin  3   4   5 , David D Dore  1   6 , Yinghui Miao  3   4 , Kathy Z Fung  3   4 , Kiya D R Komaiko  3   4 , Michael A Steinman  3   4
Affiliations

Beta-Blocker Use in U.S. Nursing Home Residents After Myocardial Infarction: A National Study

Andrew R Zullo et al. J Am Geriatr Soc. 2017 Apr.

Abstract

Objectives: To evaluate how often beta-blockers were started after acute myocardial infarction (AMI) in nursing home (NH) residents who previously did not use these drugs and to evaluate which factors were associated with post-AMI use of beta-blockers.

Design: Retrospective cohort using linked national Minimum Data Set assessments; Online Survey, Certification and Reporting records; and Medicare claims.

Setting: U.S. NHs.

Participants: National cohort of 15,720 residents aged 65 and older who were hospitalized for AMI between May 2007 and March 2010, had not taken beta-blockers for at least 4 months before their AMI, and survived 14 days or longer after NH readmission.

Measurements: The outcome was beta-blocker initiation within 30 days of NH readmission.

Results: Fifty-seven percent (n = 8,953) of residents initiated a beta-blocker after AMI. After covariate adjustment, use of beta-blockers was less in older residents (ranging from odds ratio (OR) = 0.89, 95% confidence interval (CI) = 0.79-1.00 for aged 75-84 to OR = 0.65, 95% CI = 0.54-0.79 for ≥95 vs 65-74) and less in residents with higher levels of functional impairment (dependent or totally dependent vs independent to limited assistance: OR = 0.84, 95% CI = 0.75-0.94) and medication use (≥15 vs ≤10 medications: OR = 0.89, 95% CI = 0.80-0.99). A wide variety of resident and NH characteristics were not associated with beta-blocker use, including sex, cognitive function, comorbidity burden, and NH ownership.

Conclusion: Almost half of older NH residents in the United States do not initiate a beta-blocker after AMI. The absence of observed factors that strongly predict beta-blocker use may indicate a lack of consensus on how to manage older NH residents, suggesting the need to develop and disseminate thoughtful practice standards.

Keywords: beta-blockers; drug utilization; elderly; myocardial infarction; nursing homes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of resident inclusion and exclusion in study cohort.
See this image and copyright information in PMC

References

    1. Khera S, Kolte D, Gupta T, Mujib M, Aronow WS, Agarwal P, et al. Management and outcomes of ST-elevation myocardial infarction in nursing home versus community-dwelling older patients: a propensity matched study. Journal of the American Medical Directors Association. 2014;15(8):593–599. - PubMed
    1. Rich MW, Chyun DA, Skolnick AH, Alexander KP, Forman DE, Kitzman DW, et al. Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society. Journal of the American College of Cardiology. 2016;67(20):2419–2440. - PMC - PubMed
    1. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta Blockade after myocardial infarction: systematic review and meta regression analysis. Bmj. 1999;318(7200):1730–1737. - PMC - PubMed
    1. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):529–555. - PubMed
    1. Smith SC, Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458–2473. - PubMed

Substances